Pharming Group (Netherlands) Today
| PHARM Stock | EUR 0.88 0.01 1.15% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Pharming Group is trading at 0.88 as of the 23rd of April 2024, a 1.15 percent up since the beginning of the trading day. The stock's open price was 0.87. Pharming Group has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Pharming Group NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of July 2023 and ending today, the 23rd of April 2024. Click here to learn more.
Pharming Group N.V., a specialty pharmaceutical company, develops and manufactures biopharmaceutical products in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. PHARMING GROUP operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. The company has 652.41 M outstanding shares. More on Pharming Group NV
Moving together with Pharming Stock
| 0.73 | GLPG | Galapagos NV | PairCorr |
| 0.63 | BAI | BenevolentAI SA | PairCorr |
| 0.64 | VVY | Vivoryon Therapeutics | PairCorr |
Moving against Pharming Stock
| 0.78 | EXO | Exor NV | PairCorr |
| 0.71 | ADYEN | Adyen NV | PairCorr |
| 0.6 | HAL | HAL Trust | PairCorr |
| 0.57 | ASM | ASM International Earnings Call Tomorrow | PairCorr |
| 0.54 | ASML | ASML Holding NV | PairCorr |
| 0.53 | IMCD | IMCD NV Earnings Call This Week | PairCorr |
| 0.43 | WKL | Wolters Kluwer NV | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharming Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharming Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharming Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Pharming Group NV (PHARM) is traded on Euronext Amsterdam in Netherlands and employs 277 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 811.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharming Group's market, we take the total number of its shares issued and multiply it by Pharming Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharming Group NV operates under Healthcare sector and is part of Biotechnology industry. The entity has 652.41 M outstanding shares.
Pharming Group NV has accumulated about 63.89 M in cash with 37.84 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check Pharming Group Probability Of Bankruptcy
Ownership AllocationPharming Group NV has a total of 652.41 Million outstanding shares. Roughly 82.0 pct. of Pharming Group outstanding shares are held by general public with 1.97 % owned by insiders and only 16.43 (%) by third-party entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Pharming Ownership Details
Pharming Stock Price Odds Analysis
What are Pharming Group's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Pharming Group jumping above the current price in 90 days from now is close to 99%. The Pharming Group NV probability density function shows the probability of Pharming Group stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Pharming Group has a beta of 0.4293 indicating as returns on the market go up, Pharming Group average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pharming Group NV will be expected to be much smaller as well. Additionally, pharming Group NV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Pharming Group to move above the current price in 90 days from now is close to 99 (This Pharming Group NV probability density function shows the probability of Pharming Stock to fall within a particular range of prices over 90 days) .
Pharming Group NV Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Pharming Group market risk premium is the additional return an investor will receive from holding Pharming Group long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pharming Group. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Pharming Group's alpha and beta are two of the key measurements used to evaluate Pharming Group's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.47 | |||
| Standard Deviation | 2.14 | |||
| Variance | 4.57 | |||
| Risk Adjusted Performance | (0.09) |
Pharming Stock Against Markets
Picking the right benchmark for Pharming Group stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pharming Group stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pharming Group is critical whether you are bullish or bearish towards Pharming Group NV at a given time. Please also check how Pharming Group's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharming Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Pharming Group Corporate Management
Elected by the shareholders, the Pharming Group's board of directors comprises two types of representatives: Pharming Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharming. The board's role is to monitor Pharming Group's management team and ensure that shareholders' interests are well served. Pharming Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharming Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruno Giannetti | Consultant | Profile | |
| Susanne Embleton | Investor Mang | Profile | |
| Jeroen Wakkerman | Chief Officer | Profile | |
| Ruud Outersterp | Chief Officer | Profile | |
| Stephen Toor | Chief Americas | Profile | |
| Anurag Relan | Chief Officer | Profile | |
| MBA MD | CEO Pres | Profile |
How to buy Pharming Stock?
Before investing in Pharming Group, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Pharming Group. To buy Pharming Group stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Pharming Group. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Pharming Group stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Pharming Group NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Pharming Group NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Pharming Group NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Pharming Stock please use our How to Invest in Pharming Group guide.
Already Invested in Pharming Group NV?
The danger of trading Pharming Group NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pharming Group is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pharming Group. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pharming Group NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Pharming Stock analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |